Jci_page_head_homepage_01 Jci_page_head_homepage_02
Xueliang Du, Takeshi Matsumura, Diane Edelstein, Luciano Rossetti, Zsuzsanna Zsengellér, Csaba Szabó, Michael Brownlee
Published in Volume 112, Issue 7
J Clin Invest. 2003; 112(7):1049–1057 doi:10.1172/JCI18127
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 2

Effect of GAPDH antisense ODNs on pathways of hyperglycemic damage in BAECs. (a) PKC activation; (b) hexosamine pathway activation; (c) intracellular AGE formation; (d) NF-κB activation. *P < 0.01 compared with cells incubated in 5 mM glucose. AU, arbitrary units. For a through c, each bar represents the mean ± SEM of four separate experiments. For d, each bar represents the mean ± SEM of fluorescence from 40 cells measured in an in situ DNA–protein binding assay.